EMCURE PHARMACEUTICALS
Back to Income Statement
|
EMCURE PHARMACEUTICALS Last 5 Year Operating Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹1,469 Cr | ₹1,230 Cr | ₹1,181 Cr | ₹1,330 Cr | ₹1,232 Cr |
What is the latest Operating Profit of EMCURE PHARMACEUTICALS ?
| Year | Operating Profit |
|---|---|
| Mar2026 | ₹1,469 Cr |
| Mar2025 | ₹1,230 Cr |
| Mar2024 | ₹1,181 Cr |
| Mar2023 | ₹1,330 Cr |
| Mar2022 | ₹1,232 Cr |
How is Operating Profit of EMCURE PHARMACEUTICALS Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,469 Cr | 19.45 | |
| Mar2025 | ₹1,230 Cr | 4.11 | |
| Mar2024 | ₹1,181 Cr | -11.18 | |
| Mar2023 | ₹1,330 Cr | 7.95 | |
| Mar2022 | ₹1,232 Cr | - | |
Compare Operating Profit of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹36,467.9 Cr | -1.9% | 3.5% | 52.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹432,120.0 Cr | -3.2% | -5.4% | 12% | Stock Analytics | |
| DIVIS LABORATORIES | ₹253,390.0 Cr | 0.7% | 3.2% | 61.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,740.0 Cr | -2.8% | -3% | 32.6% | Stock Analytics | |
| CIPLA | ₹108,497.0 Cr | -2.9% | -3.3% | -10.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,925.0 Cr | -3.3% | 4.7% | -2.2% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | -1.9% |
3.5% |
52.3% |
| SENSEX | -2.1% |
-5.9% |
-10.8% |
You may also like the below Video Courses